We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nontoxic QD Nanoparticles Inhibit Cancer Cell Growth

By LabMedica International staff writers
Posted on 29 May 2018
Print article
Image: Photomicrographs of A549 lung cancer cells; left = untreated; right = treated with quantum dots (Photo courtesy of Swansea University).
Image: Photomicrographs of A549 lung cancer cells; left = untreated; right = treated with quantum dots (Photo courtesy of Swansea University).
An environmentally friendly method has been developed for the production of quantum dot nanoparticles, which have antimicrobial properties and demonstrate potential for cancer diagnosis and treatment.

Low-dimensional (<10 nanometer) semiconductor quantum dots (QDs) have received great attention for potential use in biomedical applications (diagnosis and therapy) for which larger nanoparticles (>10 nanometers) are not suitable. However, the chemical synthesis of quantum dots is complicated, expensive, and has toxic side effects.

To avoid these toxic effects, investigators at Swansea University (United Kingdom) developed a non-toxic plant-based alternative method of producing quantum dots, using tealeaf extract. Extracts derived from tealeaves (Camellia sinensis) contain a wide variety of compounds, including polyphenols, amino acids, vitamins, and antioxidants. The investigators added tealeaf extract to a mixture of cadmium sulfate (CdSO4) and sodium sulfide (Na2S) and allowed the solution to incubate until quantum dots formed.

The investigators examined the biological activity of these CdS QDs in different applications, namely, (a) antibacterial activity, (b) bioimaging, and (c) apoptosis of lung cancer cells. The antibacterial activity of the CdS QDs was evaluated and showed that CdS QDs effectively inhibited bacterial growth.

The investigators further reported in the March 9, 2018, online edition of the journal Applied Nano Materials that the quantum dots exhibited cytotoxicity toward A549 lung cancer cells when compared to a control (no QD treatment). The cytotoxic effect on A549 cancer cells was comparable to that of a standard drug, cisplatin. Furthermore, these CdS QDs produced high-contrast fluorescence images of A549 cancer cells indicating a strong interaction with the cancer cell.

To further understand the role of CdS QDs in bioimaging and the cytotoxic effect in A549 cells, the investigators performed fluorescence emission and flow cytometry analyses. The flow cytometry analysis confirmed that the CdS QDs were arresting A549 cell growth at the S phase of the cell cycle, inhibiting further growth of these lung cancer cells.

Senior author Dr. Sudhagar Pitchaimuthu, senior research fellow in engineering at Swansea University, said, "Our research confirmed previous evidence that tea leaf extract can be a non-toxic alternative to making quantum dots using chemicals. The real surprise, however, was that the dots actively inhibited the growth of the lung cancer cells. We had not been expecting this. The CdS quantum dots derived from tealeaf extract showed exceptional fluorescence emission in cancer cell bioimaging compared to conventional CdS nanoparticles. Quantum dots are therefore a very promising avenue to explore for developing new cancer treatments. Building on this exciting discovery, the next step is to scale up our operation, hopefully with the help of other collaborators. We want to investigate the role of tealeaf extract in cancer cell imaging, and the interface between quantum dots and the cancer cell. We would like to set up a "quantum dot factory" which will allow us to explore more fully the ways in which they can be used."

Related Links:
Swansea University

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.